Pertussis in the Netherlands: An Outbreak Despite High Levels of Immunization with Whole-Cell Vaccine

Emerging Infectious Diseases

Volumn 3, Issue 2, 1997, Pages 175-178

  De Melker, H E ^a   Conyn van Spaendonck, M A E ^a   Rumke H C ^a   Van Wijngaarden, J K ^b   Mooi, F R ^a   Schellekens, J F P ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Inspectorate of Health   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; EPIDEMIC; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; MIDDLE AGED; NETHERLANDS; NEWBORN; PERTUSSIS; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MIDDLE AGED; NETHERLANDS; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 0031111048     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0302.970211     Document Type: Article

References (11)

1. Melker HE de, Conyn-van Spaendonck MAE, Rümke HC, Sprenger MJW, Schellekens JFP. Kinkhoest in Nederland: 1989-1994. Nederlands Tijdschrift Geneeskunde 1995;139:1280-6.
2. Zee A van der, Agterberg C, Peeters MF, Mooi F, Schellekens JFP. A clinical validation of B. (para)pertussis PCR: comparison with culture and serology using samples of patients suspected for whooping cough from a highly immunized population. J Infect Dis 1996;174:89-96.
3. Clemens JD, Ferreccio C, Levine MM, Horwitz I, Rao MR, Edwards KM, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus-pertussis vaccine. JAMA 1992;267:880-4.
4. Labadie J, Sundermann LC, Rümke HC, and the DTP-IPV∼Hib vaccine study group. Multi-center study on the simultaneous administration of DTP-IPV and Hib PRP-T vaccines. Part 1. Immunogenicity. National Institute of Public Health and the Environment (RIVM) Bilthoven, The Netherlands. Report No. 124001003, April 1996.
5. Zee A van der, Vernooij S, Peeters M, Embden J van, Mooi FR Dynamics of the population structure of Bordetella pertussis as measured by 181002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology 1996;142:3479-85.
6. Mooi FR, Oirschot H van, Peeters J, Willems RJL. Antigenic variation of the accellular vaccine component pertactin in the Dutch B. pertussis population. National Institute of Public Health and the Environment (RIVM) Bilthoven, The Netherlands. Annual Report 1995.
7. Centers for Disease Control and Prevention. Resurgence of pertussis - United States, 1993. MMWR Morb Mortal Wkly Rep 1993;42:952-3,959-60.
8. Centers for Disease Control and Prevention. Pertussis - United States, January 1992-June 1995. MMWR Morb Mortal Wkly Rep 1995;44:525-9.
9. De Serres G, Bouliane N, Douville Fradet M, Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep 1995;21:45-8.
10. Milord F. Resurgence of pertussis in Monteregie, Quebec -1990-1994. Can Commun Dis Rep 1995;21:40-4.
11. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, et al. A controlled trial of two acellular vaccines and one whole cell vaccine against pertussis. N Engl J Med 1996;334:341-8.